<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31438497</article-id>
<article-id pub-id-type="pmc">6747382</article-id>
<article-id pub-id-type="doi">10.3390/ijms20174075</article-id>
<article-id pub-id-type="publisher-id">ijms-20-04075</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Barbiero</surname>
<given-names>Isabella</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Rosa</surname>
<given-names>Roberta</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>Charlotte</given-names>
</name>
<xref ref-type="corresp" rid="c1-ijms-20-04075">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-20-04075">Department of Biotechnology and Life Sciences, (DBSV), University of Insubria, Via Manara 7, 21052 Busto Arsizio (VA), Italy</aff>
<author-notes>
<corresp id="c1-ijms-20-04075"><label>*</label>Correspondence: <email>c.kilstrup-nielsen@uninsubria.it</email>; Tel.: +39-033-133-9430</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>9</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>17</issue>
<elocation-id>4075</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>CDKL5 deficiency disorder (CDD) is a severe neurodevelopmental encephalopathy caused by mutations in the X-linked <italic>CDKL5</italic> gene that encodes a serine/threonine kinase. CDD is characterised by the early onset of seizures and impaired cognitive and motor skills. Loss of CDKL5 in vitro and in vivo affects neuronal morphology at early and late stages of maturation, suggesting a link between CDKL5 and the neuronal cytoskeleton. Recently, various microtubule (MT)-binding proteins have been identified as interactors of CDKL5, indicating that its roles converge on regulating MT functioning. MTs are dynamic structures that are important for neuronal morphology, migration and polarity. The delicate control of MT dynamics is fundamental for proper neuronal functions, as evidenced by the fact that aberrant MT dynamics are involved in various neurological disorders. In this review, we highlight the link between CDKL5 and MTs, discussing how CDKL5 deficiency may lead to deranged neuronal functions through aberrant MT dynamics. Finally, we discuss whether the regulation of MT dynamics through microtubule-targeting agents may represent a novel strategy for future pharmacological approaches in the CDD field.</p>
</abstract>
<kwd-group>
<kwd>CDKL5</kwd>
<kwd>microtubules</kwd>
<kwd>neuronal morphology</kwd>
<kwd>+TIP</kwd>
<kwd>CLIP170</kwd>
<kwd>EB1–3</kwd>
<kwd>MAP1S</kwd>
<kwd>microtubule-targeting agents</kwd>
<kwd>pregnenolone</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-20-04075" sec-type="intro">
<title>1. Introduction</title>
<p>The cyclin-dependent kinase-like 5 (<italic>CDKL5</italic>) gene is known since 1998, when it was identified in a transcriptional mapping approach to identify disease-causing genes in the Xp22 region [<xref ref-type="bibr" rid="B1-ijms-20-04075">1</xref>]. However, the gene caught significant attention only in 2003, when translocations interrupting <italic>CDKL5</italic> were identified in two female patients with severe X-linked infantile spasms and intellectual disability [<xref ref-type="bibr" rid="B2-ijms-20-04075">2</xref>]. Rapidly afterwards, in 2004, more reports described missense and frame-shift mutations in various positions of <italic>CDKL5</italic> in individuals with clinical manifestations, ranging from atypical Rett syndrome (RTT) to autism [<xref ref-type="bibr" rid="B3-ijms-20-04075">3</xref>,<xref ref-type="bibr" rid="B4-ijms-20-04075">4</xref>,<xref ref-type="bibr" rid="B5-ijms-20-04075">5</xref>]. In the following reports, mutations in <italic>CDKL5</italic> were commonly identified in patients clinically diagnosed with the early seizure variant of RTT and it was only in 2013 that the pathology associated with <italic>CDKL5</italic> deficiency was established as an independent clinical entity referred to as CDKL5 disorder [<xref ref-type="bibr" rid="B6-ijms-20-04075">6</xref>] or, lately, as CDKL5 deficiency disorder (CDD). The first clinical manifestation of CDD is normally treatment-resistant seizures that appear within the first three months after birth [<xref ref-type="bibr" rid="B7-ijms-20-04075">7</xref>]. Moreover, CDD patients are characterised by developmental delay, intellectual disability, gross motor impairment, strong hypotonia, sleep disturbances, gastrointestinal problems, breathing problems and hand stereotypies. Some of these symptoms overlap with those of RTT, and the main distinction between the two pathologies is the absence of a period of regression, which is among the diagnostic criteria for RTT [<xref ref-type="bibr" rid="B8-ijms-20-04075">8</xref>], in patients with <italic>CDKL5</italic> mutations.</p>
<p>The clinical manifestations linked to <italic>CDKL5</italic> mutations underscore the importance of the encoded serine/threonine kinase for brain functions. Studies aimed at understanding the molecular pathways controlled by CDKL5 and the neuronal and neuroanatomic consequences associated with its deficiency have in the last years provided crucial information of CDKL5 functions. Importantly, very recently, reports from more laboratories converge on a functional link between CDKL5 and microtubules (MTs) [<xref ref-type="bibr" rid="B9-ijms-20-04075">9</xref>,<xref ref-type="bibr" rid="B10-ijms-20-04075">10</xref>,<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>,<xref ref-type="bibr" rid="B12-ijms-20-04075">12</xref>]. MTs, together with actin and intermediate filaments, constitute a highly dynamic architectural element of neurons and are fundamental for intracellular cargo transport and for the accommodation of structural neuronal changes that underlie synaptic plasticity [<xref ref-type="bibr" rid="B13-ijms-20-04075">13</xref>]. Various brain disorders have been linked to mutations in genes that control MT-related processes, and the pharmacological targeting of MTs or the associated proteins are currently being tested in preclinical and clinical studies [<xref ref-type="bibr" rid="B14-ijms-20-04075">14</xref>,<xref ref-type="bibr" rid="B15-ijms-20-04075">15</xref>].</p>
<p>We will here review the recent findings regarding CDKL5 functions with particular focus on its MT-related functions and the possible translational value of these findings for CDKL5-related disorders.</p>
</sec>
<sec id="sec2-ijms-20-04075">
<title>2. Microtubules</title>
<p>Microtubules are constituted by dimers of α- and β-tubulin, polymerising in a head-to-tail fashion into proto-filaments that assemble laterally to form polarised tubular structures with so-called plus- and minus-ends exposing β- and α-tubulin, respectively [<xref ref-type="bibr" rid="B13-ijms-20-04075">13</xref>] (<xref ref-type="fig" rid="ijms-20-04075-f001">Figure 1</xref>A). Assembly requires β-tubulin to be in its guanosine triphosphate (GTP)-bound form; the rapid hydrolysis into guanosine diphosphate (GDP) upon incorporation into the MT lattice generates a GTP-cap at the plus-end, favouring further polymerisation. In most cells, MTs are nucleated from the MT-organising centre (MTOC) with the minus-end of the MTs being embedded and stabilised in the γ-tubulin ring and the plus-ends radiating into the cytoplasm. Neuronal MTs, however, are rapidly released by MT-severing proteins and then transported into the neurites as short polymers. Further, in neurons, MT nucleation can also occur independently of the MTOC [<xref ref-type="bibr" rid="B16-ijms-20-04075">16</xref>], with the minus-ends being capped and stabilised by specific proteins. The highly-polarised nature of neurons is mirrored in the organisation of the MT array: in the axon, MTs are uniformly oriented with the plus-ends facing the tip of the axon, while in dendrites they are of mixed polarity with both minus- and plus-ends pointing distally.</p>
<p>MTs are highly dynamic structures that undergo cycles of rapid growth and disassembly in a process defined as dynamic instability [<xref ref-type="bibr" rid="B13-ijms-20-04075">13</xref>] (<xref ref-type="fig" rid="ijms-20-04075-f001">Figure 1</xref>B). The switch from growth to disassembly (or shrinkage) is called “catastrophe”, while the reverse is termed “rescue”. This dynamic instability, which occurs mainly at the MT plus-ends, provides a rapid reorganisation of the cytoskeleton that is necessary for many cellular functions, such as cell division and migration and formation of cell polarity. Various factors participate in the control of dynamic instability such as the fine regulation of MT-associated proteins, among which the plus-end tracking proteins (+TIPs) play a fundamental role [<xref ref-type="bibr" rid="B17-ijms-20-04075">17</xref>], and the post-translational modifications (PTMs) of α- and β-tubulin that constitute the so-called “tubulin code” [<xref ref-type="bibr" rid="B18-ijms-20-04075">18</xref>].</p>
<p>Tubulin PTMs present different allocations on the α/β-tubulin heterodimer with respect to their position on the MT lattice: detyrosination and deglutamylation take place on the C-terminal tail of tubulin that projects away from the MT lattice and provides interaction sites for the MT-associated proteins. Conversely, acetylation of α-tubulin on lysine 40 is found on the inside of the MT lumen (<xref ref-type="fig" rid="ijms-20-04075-f001">Figure 1</xref>C) [<xref ref-type="bibr" rid="B18-ijms-20-04075">18</xref>]. Newly-synthesised α-tubulin generally contains a C-terminal tyrosine residue that undergoes enzymatic cyclic removal and re-addition. Detyrosinated MTs are normally considered stable and long-lived, even if the modification per se does not influence MT stability but rather alters the anchorage point for specific proteins. The irreversible removal of the penultimate glutamate from the primary sequence of α-tubulin, generating ∆2-tubulin, prevents α-tubulin re-tyrosination and represents a hallmark of stable MTs. Acetylation of α-tubulin on lysine 40 that, as mentioned, is located within the lumen of the MT lattice is synonymous of stable MTs. Although the causal link between tubulin PTMs and MT stability remains largely enigmatic, the consequences of their disruption can be fatal, as illustrated by animal models carrying inactivating mutations in genes encoding the modifying enzymes [<xref ref-type="bibr" rid="B19-ijms-20-04075">19</xref>].</p>
<p>As mentioned, dynamic instability is largely influenced by a plethora of proteins that bind MTs. Classical MT-associated proteins (MAPs) constitute an important group of proteins that bind along the MT lattice, influencing its polymerisation, stability and bundling. MAP1 family proteins, such as MAP1A, MAP1B and MAP1S, are high molecular weight complexes formed of heavy and light chains (LC) [<xref ref-type="bibr" rid="B20-ijms-20-04075">20</xref>]. The capacity of these proteins to bind both MTs and actin suggests that they might simultaneously bind and cross-link these two cytoskeletal components. The MAP2 family includes MAP2 and Tau that accumulate in neuronal dendrites and axons, respectively, where they promote MT stability [<xref ref-type="bibr" rid="B21-ijms-20-04075">21</xref>]. </p>
<p>The +TIP family comprises another large group of diverse proteins that share the common feature of associating with the growing MT plus-end, where they control MT dynamics and functioning [<xref ref-type="bibr" rid="B22-ijms-20-04075">22</xref>]. The plus-end tracking behaviour of these proteins can be visualised in live-imaging studies where the binding of the fluorescently tagged proteins to the growing MTs appears as comet-like dashes [<xref ref-type="bibr" rid="B23-ijms-20-04075">23</xref>]. The end-binding proteins (EBs) form the central hub of the +TIPs; indeed, they provide the attachment site for other +TIPs thanks to their autonomous binding to MT plus-ends [<xref ref-type="bibr" rid="B24-ijms-20-04075">24</xref>]. The EB family comprises EB1–3 that bind MTs through their calponin homology (CH) domain in the Ν-terminus, while they engage in specific protein interactions through C-terminal regions. The cytoskeleton-associated protein Gly-rich (CAP-Gly) domain proteins, including the cytoplasmic linker proteins (CLIP) CLIP170, CLIP115, and p150-Glued, constitute another important group of +TIPs that bind MT plus-ends indirectly via EBs but also by directly recognising the C-terminal EEY/F (glutamate-glutamate-tyrosine/phenylalanine) motif of α-tubulin [<xref ref-type="bibr" rid="B19-ijms-20-04075">19</xref>,<xref ref-type="bibr" rid="B25-ijms-20-04075">25</xref>,<xref ref-type="bibr" rid="B26-ijms-20-04075">26</xref>]. Consistently, detyrosinated α-tubulin is deprived of the binding site for the CAP-Gly proteins. Another large group of +TIPs, including proteins like the CLIP-associated proteins (CLASP), the tumour suppressor adenomatousis polyposis coli protein (APC), p140Cap, and some kinesins (KIF), is characterised by an SxIP (serine-any amino acid-isoleucine-proline) motif through which they bind the EBs [<xref ref-type="bibr" rid="B17-ijms-20-04075">17</xref>]. </p>
<p>Functionally, the +TIPs can affect MT dynamics in opposing ways with the EBs suppressing the frequency of MT catastrophes and the CLIPs promoting MT rescue [<xref ref-type="bibr" rid="B22-ijms-20-04075">22</xref>]. The +TIPs play an essential role in MT-related functions by mediating reciprocal interactions between the MT plus-ends and the cell cortex, where several of these proteins interact directly or indirectly with the actin cytoskeleton. This allows a subset of MTs to be selectively stabilised at specific sites under the cell membrane creating tracks for the delivery of proteins to the cell periphery and pulling forces on the MT network. In this way, the +TIPs are involved in various cellular processes including mitosis, cell migration and morphology [<xref ref-type="bibr" rid="B27-ijms-20-04075">27</xref>]. Regarding neurons, various stages of neuronal development such as neuronal migration, axonal growth and dendritic spine maturation are strictly controlled by the +TIPs.</p>
<p>The importance of the proper regulation of the MT network for neuronal functions has been demonstrated through the pharmacological manipulation of MT dynamics. Indeed, axon formation can be artificially induced treating unpolarised neurons with the MT-stabilising drug, taxol [<xref ref-type="bibr" rid="B28-ijms-20-04075">28</xref>]. On the other hand, both dendritic outgrowth and the maintenance of mushroom-headed spines were reduced through the inhibition of MT assembly [<xref ref-type="bibr" rid="B29-ijms-20-04075">29</xref>,<xref ref-type="bibr" rid="B30-ijms-20-04075">30</xref>]. Further, mutations in various genes encoding proteins that regulate MT dynamics can cause defects in neuronal migration and connectivity and have been linked to neurodevelopmental disorders characterised by intellectual disability and autistic features [<xref ref-type="bibr" rid="B31-ijms-20-04075">31</xref>]. </p>
<p>As mentioned, several links have recently been established between CDKL5 and MTs. Indeed, CDKL5 has recently been found to interact with the two +TIPs, CLIP170 and EB2 [<xref ref-type="bibr" rid="B9-ijms-20-04075">9</xref>,<xref ref-type="bibr" rid="B10-ijms-20-04075">10</xref>,<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>]. The latter was identified through a chemical genetic approach as a CDKL5 substrate and was thoroughly characterised as a bona fide phosphorylation target of CDKL5 in vitro and in vivo; the functional consequences of this event are still unknown, however [<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>], and neuronal functions of EB2 have not been described so far. CLIP170 was related functionally to CDKL5 through the identification of IQ motif containing GTPase activating protein 1 (IQGAP1) as a novel CDKL5 interactor [<xref ref-type="bibr" rid="B9-ijms-20-04075">9</xref>]. IQGAP1 is an actin-binding protein that binds CLIP170 in a Rac1-dependent manner, facilitating the transient capture of MTs at specific cortical sites under the cell membrane [<xref ref-type="bibr" rid="B32-ijms-20-04075">32</xref>,<xref ref-type="bibr" rid="B33-ijms-20-04075">33</xref>]. Further, MAP1S, the less characterised member of the MAP1 family proteins, was identified as a substrate of CDKL5 through two different approaches providing strong support of a functional role of this association [<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>,<xref ref-type="bibr" rid="B12-ijms-20-04075">12</xref>].</p>
<p>Since the discovery of the first patients with <italic>CDKL5</italic> mutations, CDKL5 functions have been studied in vitro and in vivo in proliferating cells, primary neurons, in mouse models carrying inactivating deletions of the <italic>Cdkl5</italic>-gene and in human induced pluripotent stem cells (iPSC)-derived neurons [<xref ref-type="bibr" rid="B34-ijms-20-04075">34</xref>]. The overall picture emerging from these studies indicates that CDKL5 deficiency impacts cell proliferation, neuronal migration, and various aspects of neuronal morphology that are all processes that are strictly influenced by MT dynamics. These findings, demonstrating that CDKL5 functions converge on MT dynamics, may, therefore, provide a key to understand the mechanisms underlying CDD in more details.</p>
</sec>
<sec id="sec3-ijms-20-04075">
<title>3. Neuronal CDKL5 Related Defects</title>
<sec id="sec3dot1-ijms-20-04075">
<title>3.1. Axon Formation</title>
<p>In primary low-density cultures of hippocampal neurons, CDKL5 controls axon specification and outgrowth [<xref ref-type="bibr" rid="B35-ijms-20-04075">35</xref>,<xref ref-type="bibr" rid="B36-ijms-20-04075">36</xref>]. Axon elongation relies on the formation of stable MTs in the axonal shaft. These MTs form bundles covered with the axon specific MAP, Tau, and are organised in a polarised fashion, with the plus-ends oriented towards the peripheral tip. Such MT organisation generates tracks that facilitate the transport of proteins and organelles, thus providing the building blocks for new axonal segments. The axonal tip is characterised by a fan-shaped, motile structure, the growth cone, that probes the extracellular environment. In this way axon elongation and steering is directed in a process that depends on the complex remodelling and reorganisation of MTs and actin (<xref ref-type="fig" rid="ijms-20-04075-f002">Figure 2</xref>). The growth cone comprises the central region, enriched in MTs, and the peripheral domain, which is mainly composed of filamentous actin (F-actin); the two regions are separated by the transition zone in which actin arcs form a barrier against the extension of MTs into the peripheral zone [<xref ref-type="bibr" rid="B37-ijms-20-04075">37</xref>]. Few MTs are capable of escaping the central domain and reach the growth cone periphery where they, thanks to the +TIPs, can couple to F-actin and associate with specific sites at the growth cone cortex. In particular, the +TIP CLIP170 accumulates in the axonal growth cone by binding to tyrosinated tubulin [<xref ref-type="bibr" rid="B19-ijms-20-04075">19</xref>,<xref ref-type="bibr" rid="B38-ijms-20-04075">38</xref>]. Interfering with CLIP170 expression impairs axon formation in primary neurons. This is accompanied by a reduced capacity of MTs to penetrate the actin arcs and protrude into the peripheral domain [<xref ref-type="bibr" rid="B39-ijms-20-04075">39</xref>]. CDKL5 deficiency reduces the association of CLIP170 to MTs in proliferating cells and in the axonal growth cone of <italic>Cdkl5</italic>-KO neurons, which in both cases is accompanied by altered MT dynamics [<xref ref-type="bibr" rid="B9-ijms-20-04075">9</xref>,<xref ref-type="bibr" rid="B40-ijms-20-04075">40</xref>]. The binding of CLIP170 to MTs occurs when the protein is in its open active conformation whereas the intramolecular interaction between its terminal CAP-Gly domain and zinc-knuckle motifs causes a closed inactive conformation [<xref ref-type="bibr" rid="B41-ijms-20-04075">41</xref>]. Interestingly, the neurosteroid pregnenolone (PREG), which induces the open conformation of CLIP170 through its direct binding to the protein [<xref ref-type="bibr" rid="B42-ijms-20-04075">42</xref>], is capable of normalising the MT-binding of CLIP170 and restore axon specification and elongation in CDKL5 deficient neurons [<xref ref-type="bibr" rid="B9-ijms-20-04075">9</xref>]. It thus seems likely that CDKL5 is involved in maintaining CLIP170 in its active conformation. The switching between the open and closed conformation of CLIP170 is known to depend on specific phosphorylation events. Whether CDKL5 regulates CLIP170 in a phosphorylation-dependent manner is still not known.</p>
<p>In the past, CDKL5 was proposed to affect axon formation through its interaction with Shootin1 [<xref ref-type="bibr" rid="B35-ijms-20-04075">35</xref>]. Shootin1 is a key determinant for axon specification [<xref ref-type="bibr" rid="B43-ijms-20-04075">43</xref>]; it was found to act as a clutch molecule that produces the traction force for axon outgrowth by coupling the retrograde flow of F-actin and cell adhesions [<xref ref-type="bibr" rid="B44-ijms-20-04075">44</xref>]. Considering the novel link with CLIP170 it, thus, appears that CDKL5 may influence axon formation in different ways.</p>
</sec>
<sec id="sec3dot2-ijms-20-04075">
<title>3.2. Dendritic Arborisation </title>
<p>CDKL5 deficiency was first shown, through silencing studies, to influence dendritic arborisation in vitro in primary cultures of rat cortical neurons and in vivo in migrating neurons derived from silenced neural progenitor cells [<xref ref-type="bibr" rid="B45-ijms-20-04075">45</xref>]. Such defect has later been confirmed in cortical and hippocampal pyramidal neurons in <italic>Cdkl5</italic>-KO brains [<xref ref-type="bibr" rid="B46-ijms-20-04075">46</xref>,<xref ref-type="bibr" rid="B47-ijms-20-04075">47</xref>,<xref ref-type="bibr" rid="B48-ijms-20-04075">48</xref>] and reproduced in vitro in <italic>Cdkl5</italic>-KO primary hippocampal neurons [<xref ref-type="bibr" rid="B36-ijms-20-04075">36</xref>,<xref ref-type="bibr" rid="B40-ijms-20-04075">40</xref>]. The penetrance of the phenotype in vitro may depend on the experimental conditions since contrasting data have been reported [<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>].</p>
<p>The control of CDKL5 on dendrite morphology was found to occur through Rac1, which is a critical regulator of actin remodelling. Recombinant CDKL5 was capable of pulling out Rac1 from neuronal lysates, an interaction that was further stimulated upon prior neuronal stimulation with brain-derived neurotrophic factor (Bdnf). Further, Bdnf activation of Rac1 was impaired in CDKL5 silenced cells, thus placing Rac1 downstream the kinase [<xref ref-type="bibr" rid="B45-ijms-20-04075">45</xref>]. The exact mechanism through which CDKL5 activates Rac1 is unknown; however, it may be relevant to consider that CDKL5 controls the stability of the ternary IQGAP1/CLIP170/Rac1 complex [<xref ref-type="bibr" rid="B9-ijms-20-04075">9</xref>]. IQGAP1 is widely implicated in Rac1/cdc42 signalling [<xref ref-type="bibr" rid="B49-ijms-20-04075">49</xref>]. Indeed, IQGAP1 maintains the two small GTPases in their active GTP-bound state and acts as a scaffolding platform for Rac1/cdc42 signalling by recruiting their downstream effector proteins. Further, CLIP170 and IQGAP1 were reported to cooperate in controlling dendrite morphology, apparently by bridging MTs and the actin cytoskeleton [<xref ref-type="bibr" rid="B50-ijms-20-04075">50</xref>]. Reduced CLIP170 or IQGAP1 levels led to the formation of a less complex dendritic arbor, a phenotype that resembles the one linked to CDKL5 deficiency and that could be prevented through the pharmacological stabilisation of F-actin. CDKL5 may, thus, control the cytoskeleton dynamics involved in dendrite morphology by allowing the formation of the protein complex mediating Rac1 activation and bridging the MT and actin networks.</p>
<p>Another possible way in which CDKL5 regulates MT dynamics during dendritic arborisation may be represented by the phosphorylation on MAP1S, recently identified as a bona fide substrate of CDKL5 [<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>,<xref ref-type="bibr" rid="B12-ijms-20-04075">12</xref>] (<xref ref-type="fig" rid="ijms-20-04075-f003">Figure 3</xref>). When phosphorylated on two serines (Ser786 and Ser812), located within the LC, MAP1S LCs have reduced affinity for MTs and appear to be more soluble. Interestingly, overexpression of phospho-defective MAP1S LCs in neurons forced the dendritic tips to settle in an aberrant looped conformation. In line with the capacity of MAP1 family members to increase MT stability [<xref ref-type="bibr" rid="B51-ijms-20-04075">51</xref>], functional studies suggested that the increased binding of MAP1S to MTs in the absence of CDKL5 leads to less dynamic MT plus-ends. Indeed, EB3-GFP (green fluorescent protein) comets, the fluorescence of which over time is a measure of MT dynamicity, are longer lived in <italic>Cdkl5</italic>-KO neurons, but are restored to normal life-times upon MAP1S silencing [<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>].</p>
</sec>
<sec id="sec3dot3-ijms-20-04075">
<title>3.3. Dendritic Spines</title>
<p>Various studies in vitro and in vivo converge on a role of CDKL5 in controlling dendritic spine morphology and excitatory functions. Neurons devoid of CDKL5 are characterised by an increased number of filopodia-like protrusions and a reduced number of mushroom-shaped spines [<xref ref-type="bibr" rid="B52-ijms-20-04075">52</xref>,<xref ref-type="bibr" rid="B53-ijms-20-04075">53</xref>]. The enlarged spine heads, which distinguish mushroom-shaped spines, correlate with increased synaptic strength. Various neurologic conditions characterised by cognitive dysfunctions and autistic features have been linked to altered density and shape of dendritic spines [<xref ref-type="bibr" rid="B54-ijms-20-04075">54</xref>]. CDKL5 is readily detectable in dendritic spines, where its synaptic accumulation is regulated both by the dendritic targeting of its mRNA, which undergoes local activity-dependent translation, and through its interaction with post-synaptic density protein 95 (PSD95) [<xref ref-type="bibr" rid="B52-ijms-20-04075">52</xref>,<xref ref-type="bibr" rid="B55-ijms-20-04075">55</xref>,<xref ref-type="bibr" rid="B56-ijms-20-04075">56</xref>]. CDKL5 is, thus, likely to influence directly various proteins involved in excitatory neurotransmission. Accordingly, CDKL5 affects the expression or phosphorylation of the post-synaptic markers PSD95, Homer, the α-amino-3-hydroxy-5-methylisozasole-4-propionic acid (AMPA)-receptor subunit GluA2, and NGL1 [<xref ref-type="bibr" rid="B52-ijms-20-04075">52</xref>,<xref ref-type="bibr" rid="B56-ijms-20-04075">56</xref>,<xref ref-type="bibr" rid="B57-ijms-20-04075">57</xref>,<xref ref-type="bibr" rid="B58-ijms-20-04075">58</xref>]. So far, we have very little information whether the neuroanatomical and molecular alterations in CDD mouse models are present also in the patients. However, reduced membrane levels of GluA2, which have been observed in vitro in neurons silenced for CDKL5 expression and in vivo in the hippocampus and perirhinal cortex of two mouse models of CDD, were recently confirmed in post-mortem brains from two CDD patients [<xref ref-type="bibr" rid="B58-ijms-20-04075">58</xref>,<xref ref-type="bibr" rid="B59-ijms-20-04075">59</xref>,<xref ref-type="bibr" rid="B60-ijms-20-04075">60</xref>], suggesting the relevance of at least some CDKL5-related defects for the human pathology.</p>
<p>Plasticity-related changes in spine morphology are widely known to rely on remodelling of the actin cytoskeleton, which is highly enriched in dendritic protrusions [<xref ref-type="bibr" rid="B61-ijms-20-04075">61</xref>]. MTs were for many years ignored as an integral part of dendritic spines; however, live imaging studies of fluorescently-tagged EB3, marking dynamic MTs, combined with other techniques, have allowed demonstrating that MTs do actually polymerise into dendritic spines in a rapid and transient manner [<xref ref-type="bibr" rid="B30-ijms-20-04075">30</xref>,<xref ref-type="bibr" rid="B62-ijms-20-04075">62</xref>,<xref ref-type="bibr" rid="B63-ijms-20-04075">63</xref>] (<xref ref-type="fig" rid="ijms-20-04075-f004">Figure 4</xref>). The incursion of MTs into the spines is activity-dependent and contributes to the formation of mature dendritic spines. Actually, nocodazole-mediated inhibition of dynamic MTs impedes the Bdnf-induced structural changes that leads to the maturation of filopodia-like protrusions into mushroom-shaped spines [<xref ref-type="bibr" rid="B63-ijms-20-04075">63</xref>]. The +TIP EB3 plays an active role in MT-dependent structural plasticity; actually, its silencing leads to a reduced number of mushroom-shaped spines. Paralleling the importance of a cross-talk between MTs and the actin cytoskeleton in the axonal growth cone, EB3 was found to provide a link to the actin cytoskeleton in the spines. Indeed, interactions between MT-bound EB3 with p140Cap and the actin stabilising factor cortactin is likely to create local signalling events that allow MT-actin communication in “activated” spines [<xref ref-type="bibr" rid="B30-ijms-20-04075">30</xref>]. Interestingly, the actin–MT cooperation seems, in turn, to be enhanced by neuronal network activation; indeed, very recent data suggest that MT invasion occurs in specific spines through N-methyl-D-aspartate (NMDA)-receptor-mediated calcium influx that leads to actin remodelling at the base of the spine, thus allowing the targeting of the MTs [<xref ref-type="bibr" rid="B64-ijms-20-04075">64</xref>].</p>
<p>Regarding a possible role of CDKL5 in regulating spine morphogenesis through MT-related events, it is tempting to speculate that more +TIPs may be involved in regulating spine morphogenesis and functions creating other distinct links between MTs and the actin cytoskeleton. This would allow an expansion in the repertoire of possible signalling events underlying structural plasticity. While EB2 is broadly expressed in the neuronal soma, its levels are very low in the post-synaptic compartment [<xref ref-type="bibr" rid="B65-ijms-20-04075">65</xref>]. Accordingly, CDKL5-dependent phosphorylation of EB2 on serine 223 can readily be detected in the proximal dendrites of patient iPSC-derived neurons [<xref ref-type="bibr" rid="B11-ijms-20-04075">11</xref>]. The presence of CLIP170 in dendritic spines has so far not been reported. However, IQGAP1, which interacts with both CDKL5 and CLIP170, is present in spines [<xref ref-type="bibr" rid="B66-ijms-20-04075">66</xref>], where it regulates spine morphogenesis [<xref ref-type="bibr" rid="B67-ijms-20-04075">67</xref>], and <italic>Iqgap1</italic>-KO mice display cognitive defects and impaired long-term potentiation (LTP) [<xref ref-type="bibr" rid="B68-ijms-20-04075">68</xref>]. IQGAP1 interacts with various post-synaptic proteins such as the AMPA-receptor GluA4, PSD95 and the NMDA-receptor complex [<xref ref-type="bibr" rid="B68-ijms-20-04075">68</xref>,<xref ref-type="bibr" rid="B69-ijms-20-04075">69</xref>]; it is, thus, intriguing to speculate that its interaction with CLIP170 might serve a role in regulating spine formation and functioning. Of further interest, disks large homolog 5 (DLG5), which was identified as a cellular substrate of CDKL5 [<xref ref-type="bibr" rid="B12-ijms-20-04075">12</xref>], is an important regulator of dendritic spine formation [<xref ref-type="bibr" rid="B70-ijms-20-04075">70</xref>]. DLG5 is member of the membrane-associated guanylate kinase (MAGUK) proteins and appears to control spine formation by facilitating the localisation of N-cadherin to the cell membrane. A possible link between DLG5 and MTs can be hypothesised based on its interaction with MARK3 (MT affinity regulating kinase 3), a kinase that controls cell polarity through the phosphorylation of specific MAPs, thus regulating their affinity for MTs [<xref ref-type="bibr" rid="B71-ijms-20-04075">71</xref>].</p>
<p>Considering that MTs constitute fundamental tracks for the motor-based transport of cargoes, their invasion into dendritic spines is likely to provide a way of transporting cargoes into and out of these structures. The nature of which cargoes enter spines through MTs is still not clear. However, synaptotagmin has been found to be transported in a kinesin-dependent manner into dendritic spines [<xref ref-type="bibr" rid="B72-ijms-20-04075">72</xref>]. Further studies will be relevant to analyse the contribution of altered MT dynamics to CDKL5-related spine defects and which cargoes might be influenced by CDKL5 deficiency.</p>
</sec>
</sec>
<sec id="sec4-ijms-20-04075">
<title>4. Non-Neuronal CDKL5-Related Defects</title>
<p>The role of CDKL5 in regulating MT dynamics is consistent with our previous report that described CDKL5 as a centrosomal protein [<xref ref-type="bibr" rid="B10-ijms-20-04075">10</xref>]. The centrosome is a central component of the cytoskeletal structure and consists of a scaffold core containing a large number of proteins, including γ-tubulin and the γ-tubulin ring complex (γ-TuRC) that typically surrounds a pair of cylindrical centrioles enclosed in the amorphous pericentriolar material (PCM) [<xref ref-type="bibr" rid="B73-ijms-20-04075">73</xref>]. The centrosome is the primary MT-organising centre of the cells and, therefore, participates in fundamental cellular functions, such as cell motility, migration, polarity [<xref ref-type="bibr" rid="B74-ijms-20-04075">74</xref>,<xref ref-type="bibr" rid="B75-ijms-20-04075">75</xref>] and in the assembly and organisation of the mitotic spindle [<xref ref-type="bibr" rid="B76-ijms-20-04075">76</xref>,<xref ref-type="bibr" rid="B77-ijms-20-04075">77</xref>]. CDKL5 silencing causes an increase in the number of defective multipolar spindles, which is associated with polyploidisation and centrosome accumulation [<xref ref-type="bibr" rid="B10-ijms-20-04075">10</xref>]. It is interesting to note that CDKL5 was recently found to interact with and phosphorylate the centrosomal protein CEP131 on serine 35 [<xref ref-type="bibr" rid="B12-ijms-20-04075">12</xref>]. The functional role of this phosphorylation event was not further explored; however, silencing of CEP131 has been reported to cause centriole amplification and chromosomal instability [<xref ref-type="bibr" rid="B78-ijms-20-04075">78</xref>], a phenotype that overlaps the one caused by CDKL5 deficiency [<xref ref-type="bibr" rid="B10-ijms-20-04075">10</xref>]. Furthermore, CDKL5 and CEP131 share a common role in ciliogenesis [<xref ref-type="bibr" rid="B79-ijms-20-04075">79</xref>,<xref ref-type="bibr" rid="B80-ijms-20-04075">80</xref>]. The primary cilium is a eukaryotic organelle that is present on most quiescent and differentiated cells; it originates from a centrosome-derived structure, the basal body, and is composed by a central MT structure, the axoneme. The primary cilium acts as a cellular antenna that transmits signals from the extracellular environment to the inner site of the cell, thereby contributing to the regulation of numerous cellular processes such as proliferation, differentiation, migration and cell polarity [<xref ref-type="bibr" rid="B81-ijms-20-04075">81</xref>]. Interestingly, defects in cilia morphogenesis and functioning have been associated with a large list of heterogeneous genetic disorders, known as ciliopathies [<xref ref-type="bibr" rid="B82-ijms-20-04075">82</xref>]. Among the various clinical manifestations linked to ciliary dysfunctions, some share an overlap with those of CDD such as developmental delay, epilepsy, cognitive dysfunction and aberrant respiration. Cilium length appears to be influenced by CDKL5 levels [<xref ref-type="bibr" rid="B79-ijms-20-04075">79</xref>,<xref ref-type="bibr" rid="B83-ijms-20-04075">83</xref>]; a further understanding of how CDKL5 dysfunction impacts ciliary functions and the contribution of CEP131 and MT dynamics may pave the way for new perspectives in the CDKL5 field.</p>
</sec>
<sec id="sec5-ijms-20-04075">
<title>5. Possible Functional Outcome of Specific Pathogenic CDKL5 Mutations</title>
<p>The above studies linking CDKL5 to MT-related functions have been addressed in cells or tissues silenced for CDKL5 or with no expression of the protein. This reflects well the current view that CDD is caused by the absence of functional CDKL5 or by the expression of hypomorphic derivatives. Indeed, CDD-causing mutations in <italic>CDKL5</italic> include missense mutations, nonsense, frame-shift and splicing variants, and large genomic deletions [<xref ref-type="bibr" rid="B84-ijms-20-04075">84</xref>]. The pathogenic missense mutations, which have been identified so far, fall almost exclusively within the catalytic domain of the protein. Functional studies based on the exogenous expression of mutated CDKL5 derivatives suggest that amino acid substitutions within the kinase domain impact negatively its catalytic activity [<xref ref-type="bibr" rid="B79-ijms-20-04075">79</xref>,<xref ref-type="bibr" rid="B85-ijms-20-04075">85</xref>,<xref ref-type="bibr" rid="B86-ijms-20-04075">86</xref>,<xref ref-type="bibr" rid="B87-ijms-20-04075">87</xref>]. Although these studies have highlighted the impact of missense mutations on CDKL5 functioning, it needs to be underlined that only very few of these mutations have been studied; we therefore cannot exclude that other missense mutations may generate hypermorphic CDKL5 derivatives. Regarding the nonsense and frame-shift variants, nonsense-mediated decay of the mutated mRNA is likely to impede the expression of the encoded protein, thus acting as hypomorphic or null mutations [<xref ref-type="bibr" rid="B84-ijms-20-04075">84</xref>,<xref ref-type="bibr" rid="B88-ijms-20-04075">88</xref>,<xref ref-type="bibr" rid="B89-ijms-20-04075">89</xref>]. </p>
<p>The existing animal models of CDD have addressed the consequences of the absence of CDKL5 either in the whole body or in distinct brain areas [<xref ref-type="bibr" rid="B46-ijms-20-04075">46</xref>,<xref ref-type="bibr" rid="B47-ijms-20-04075">47</xref>,<xref ref-type="bibr" rid="B48-ijms-20-04075">48</xref>,<xref ref-type="bibr" rid="B90-ijms-20-04075">90</xref>]. Recently, studies were performed in a mouse line expressing the pathogenic R59X allele, but since this causes the absence of CDKL5, it can be considered a functional null [<xref ref-type="bibr" rid="B60-ijms-20-04075">60</xref>,<xref ref-type="bibr" rid="B91-ijms-20-04075">91</xref>]. Although the generation of CDD mouse models has been extremely useful to deeply understand the roles of CDKL5, an important aspect that still remains to be addressed is how the expression of pathogenic hypomorphic CDKL5 derivatives affects neuronal functions. Hypothetically, such derivatives could behave as dominant negatives and interfere with the normal function of CDKL5 interactors, such as the MT-interacting proteins. Of relevance, CDKL5 localisation and cilium length is influenced by the expression of CDKL5 derivatives containing CDD-causing missense mutations that have not yet been characterised for the catalytic activity [<xref ref-type="bibr" rid="B79-ijms-20-04075">79</xref>]. While the field is awaiting such animal models, primary fibroblasts and iPSC-derived neurons obtained from CDD patients will be very informative. Finally, it must be remembered that large genomic duplications, including <italic>CDKL5</italic>, have been identified in individuals with varying degrees of macrocephaly and learning disabilities [<xref ref-type="bibr" rid="B92-ijms-20-04075">92</xref>], suggesting the relevance of analysing the effect of increased CDKL5 levels on MT-related functions.</p>
</sec>
<sec id="sec6-ijms-20-04075">
<title>6. Therapeutic Relevance of CDKL5-Dependent MT Defects</title>
<p>Alterations of the MT cytoskeleton have been linked to neurodegenerative and neurodevelopmental disorders such as schizophrenia and autism and major depression disorder [<xref ref-type="bibr" rid="B15-ijms-20-04075">15</xref>,<xref ref-type="bibr" rid="B93-ijms-20-04075">93</xref>]. Efforts have, therefore, been put into the development of therapeutic strategies targeting the neuronal cytoskeleton for these disorders [<xref ref-type="bibr" rid="B14-ijms-20-04075">14</xref>,<xref ref-type="bibr" rid="B94-ijms-20-04075">94</xref>]. The pharmacological stabilisation of MTs with the consequent block of mitosis has for decades been used for cancer treatment; the possibility of repositioning these drugs has been considered for brain disorders. MT-stabilising drugs were initially considered for neurodegenerative disorders that are characterised by compromised tau functions and altered MT structure and axonal transport [<xref ref-type="bibr" rid="B94-ijms-20-04075">94</xref>]. Taxol (paclitaxel) promotes MT stability by binding within the MT lumen and increasing the lateral interactions between adjacent proto-filaments [<xref ref-type="bibr" rid="B95-ijms-20-04075">95</xref>]. When considering the use of MT-stabilising drugs for brain disorders, it is fundamental to consider their capacity to pass the blood–brain barrier and their possible neuropathy side effects. While proof-of-principle studies supported the beneficial effect of taxol-mediated MT stabilisation on a mouse model presenting tau pathology in spinal motor neurons [<xref ref-type="bibr" rid="B96-ijms-20-04075">96</xref>], this drug has a limited bioavailability in brain since it does not cross the blood–brain barrier. As taxol, Epothilone D (EpoD) binds and stabilises MTs, but it has the advantage of being brain penetrant, thus holding a stronger therapeutic potential for brain disorders [<xref ref-type="bibr" rid="B97-ijms-20-04075">97</xref>]. EpoD has been tested in animal models of tauopathies where doses much lower (1/30) than those used in cancer trials were found to be effective in stabilising MTs and to be capable of reducing cognitive deficits present in these models [<xref ref-type="bibr" rid="B98-ijms-20-04075">98</xref>,<xref ref-type="bibr" rid="B99-ijms-20-04075">99</xref>]. While EpoD and other drugs with similar MT-stabilising activities may possess interesting therapeutic potentials for patients with neurodegenerative diseases, their clinical application for young patient groups, as for example CDD, is more difficult to imagine. Drugs that bind MTs directly will impact MT stability in a non-specific manner and may, thus, have broad and non-advantageous effects on neurodevelopmental processes that are still ongoing in young patients. The use of drugs that target MT-binding proteins may act more specifically and, therefore, represent valid therapeutic options. An interesting molecule is represented by NAP/davunetide, an eight amino acid peptide that is derived from the activity-dependent neuroprotective protein (ADNP) [<xref ref-type="bibr" rid="B100-ijms-20-04075">100</xref>]. ADNP is a versatile protein interacting with SWI/SNF chromatin remodelling complexes and with the +TIPs EB1 and EB3 [<xref ref-type="bibr" rid="B101-ijms-20-04075">101</xref>,<xref ref-type="bibr" rid="B102-ijms-20-04075">102</xref>]. Mutations in <italic>ADNP</italic> have been linked to autism and intellectual disability, and <italic>Adnp</italic> haploinsufficiency in mice is linked to altered axonal transport and dendritic spine alterations [<xref ref-type="bibr" rid="B103-ijms-20-04075">103</xref>]. The NAP peptide interacts with the EB-proteins and promotes axonal transport and MT stability [<xref ref-type="bibr" rid="B104-ijms-20-04075">104</xref>]. In pre-clinical studies in mouse models of various neurodegenerative diseases NAP shows neuroprotection and improves cognitive defects [<xref ref-type="bibr" rid="B105-ijms-20-04075">105</xref>]. In clinical studies, intra-nasal administration of NAP led to improved cognitive skills in Alzheimer’s disease patients [<xref ref-type="bibr" rid="B106-ijms-20-04075">106</xref>] and daily activities in schizophrenic patients [<xref ref-type="bibr" rid="B107-ijms-20-04075">107</xref>]. </p>
<p>The possibility of targeting of proteins that have been functionally linked to CDKL5 might hold an even higher therapeutic potential for CDD. Interestingly, the neuroactive steroid PREG was found to directly bind CLIP170, inducing its open active conformation, as well as MAP2 [<xref ref-type="bibr" rid="B108-ijms-20-04075">108</xref>]. Notably, the treatment of CDKL5-silenced cells with PREG was capable of restoring the MT association of GFP-CLIP170 comets and neuronal defects linked to CDKL5 deficiency [<xref ref-type="bibr" rid="B9-ijms-20-04075">9</xref>]. Treatment with PREG is known to enhance memory and cognition in rodents [<xref ref-type="bibr" rid="B109-ijms-20-04075">109</xref>]. Further, clinical testing in humans indicated potential anti-depressive and anti-psychotic effects and a positive safety profile [<xref ref-type="bibr" rid="B110-ijms-20-04075">110</xref>,<xref ref-type="bibr" rid="B111-ijms-20-04075">111</xref>]. However, the clinical application of PREG is limited due to its short half-life and its conversion into other neuroactive steroids that altogether possess a broad range of activities acting at the genomic level and with numerous membrane-bound receptors [<xref ref-type="bibr" rid="B108-ijms-20-04075">108</xref>]. The development and testing of synthetic derivatives with improved stability and that cannot be metabolised into the downstream steroids might represent a possibility for CDD. Of note, MAPREG is a synthetic PREG derivative that has anti-depressant activities in rat models of depression [<xref ref-type="bibr" rid="B112-ijms-20-04075">112</xref>] and in the primate-like tree-shrew [<xref ref-type="bibr" rid="B113-ijms-20-04075">113</xref>]. Like PREG, MAPREG/MAP4343 promotes MT dynamics apparently through its binding to MAP2. Through further studies it might be relevant to analyse the therapeutic potential of this or similar PREG derivatives on CDKL5-deficient neurons.</p>
<p>To conclude, the last findings of CDKL5 functions converging on MT dynamics are likely to be of great relevance not only for a deeper understanding of the neuronal dysfunctions linked to CDKL5 deficiency but also for the development of disease-modifying pharmacological approaches. Importantly, they may also lead to the identification of clinical diagnostic biomarkers. However, before considering MT-targeting drugs for clinical applications for CDD, we still need to understand in more detail how precisely CDKL5 deficiency affects MT dynamics.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank the Italian parents’ association l’Albero di Greta for the financial support of the laboratory.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>C.K.N. and I.B., writing—original draft preparation; R.D.R., reviewing, editing, figure preparation.</p>
</notes>
<notes>
<title>Funding</title>
<p>This work was supported by funding from the Telethon Foundation grant (GGP15098) to CKN.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflicts of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">+TIP</td>
<td align="left" colspan="1" rowspan="1" valign="top">plus-end tracking protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ADNP</td>
<td align="left" colspan="1" rowspan="1" valign="top">activity-dependent neuroprotective protein </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AMPA</td>
<td align="left" colspan="1" rowspan="1" valign="top">α-amino-3-hydroxy-5-methylisozasole-4-propionic acid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">APC</td>
<td align="left" colspan="1" rowspan="1" valign="top">adenomatousis polyposis coli</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bdnf</td>
<td align="left" colspan="1" rowspan="1" valign="top">brain-derived neurotrophic factor</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CAP-Gly</td>
<td align="left" colspan="1" rowspan="1" valign="top">cytoskeleton-associtated protein Gly-rich</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CDD</td>
<td align="left" colspan="1" rowspan="1" valign="top">CDKL5 deficiency disorder</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CDKL5</td>
<td align="left" colspan="1" rowspan="1" valign="top">cyclin-dependent kinase-like 5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CH</td>
<td align="left" colspan="1" rowspan="1" valign="top">calponin homology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CLASP</td>
<td align="left" colspan="1" rowspan="1" valign="top">CLIP-associated protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CLIP</td>
<td align="left" colspan="1" rowspan="1" valign="top">cytoplasmic linker protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DLG5</td>
<td align="left" colspan="1" rowspan="1" valign="top">disks large homolog 5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">E</td>
<td align="left" colspan="1" rowspan="1" valign="top">glutamate</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">EB</td>
<td align="left" colspan="1" rowspan="1" valign="top">end-binding protein </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">EEY/F</td>
<td align="left" colspan="1" rowspan="1" valign="top">glutamate-glutamate-tyrosine/phenylalanine </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">EpoD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epothilone D </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">F-actin</td>
<td align="left" colspan="1" rowspan="1" valign="top">filamentous actin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">γ-TuRC</td>
<td align="left" colspan="1" rowspan="1" valign="top">γ-tubulin ring complex</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GFP</td>
<td align="left" colspan="1" rowspan="1" valign="top">green fluorescent protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GTP</td>
<td align="left" colspan="1" rowspan="1" valign="top">guanine triphospate</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GDP</td>
<td align="left" colspan="1" rowspan="1" valign="top">guanine diphosphate</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">IQGAP1</td>
<td align="left" colspan="1" rowspan="1" valign="top">IQ motif containing GTPase activating protein 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">iPSC</td>
<td align="left" colspan="1" rowspan="1" valign="top">induced pluripotent stem cell</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">K</td>
<td align="left" colspan="1" rowspan="1" valign="top">lysine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">KIF</td>
<td align="left" colspan="1" rowspan="1" valign="top">kinesin</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LC</td>
<td align="left" colspan="1" rowspan="1" valign="top">light chain</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">LTP</td>
<td align="left" colspan="1" rowspan="1" valign="top">long-term potentiation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MAGUK</td>
<td align="left" colspan="1" rowspan="1" valign="top">membrane-associated guanylate kinase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MAP</td>
<td align="left" colspan="1" rowspan="1" valign="top">microtubule associated protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MARK3</td>
<td align="left" colspan="1" rowspan="1" valign="top">MT affinity regulating kinase 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MT</td>
<td align="left" colspan="1" rowspan="1" valign="top">microtubule</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MTOC</td>
<td align="left" colspan="1" rowspan="1" valign="top">microtubule organising centre </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">NMDA</td>
<td align="left" colspan="1" rowspan="1" valign="top">N-methyl-D-aspartate </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PCM</td>
<td align="left" colspan="1" rowspan="1" valign="top">pericentriolar material </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PREG</td>
<td align="left" colspan="1" rowspan="1" valign="top">pregnenolone</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PSD95</td>
<td align="left" colspan="1" rowspan="1" valign="top">post-synaptic density protein 95</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PTM</td>
<td align="left" colspan="1" rowspan="1" valign="top">post-translational modification</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RTT</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SxIP</td>
<td align="left" colspan="1" rowspan="1" valign="top">serine-any protein-isoleucine-proline</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Y</td>
<td align="left" colspan="1" rowspan="1" valign="top">tyrosine</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-ijms-20-04075">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Andolfi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Caruso</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Buchner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Walpole</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Mariani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Consalez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Trump</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ballabio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region</article-title>
<source/>Genomics
          <year>1998</year>
<volume>51</volume>
<fpage>427</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1006/geno.1998.5391</pub-id>
<pub-id pub-id-type="pmid">9721213</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-20-04075">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalscheuer</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hollway</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schwinger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kübart</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Menzel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hoeltzenbein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tommerup</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Eyre</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation</article-title>
<source/>Am. J. Hum. Genet.
          <year>2003</year>
<volume>72</volume>
<fpage>1401</fpage>
<lpage>1411</lpage>
<pub-id pub-id-type="doi">10.1086/375538</pub-id>
<pub-id pub-id-type="pmid">12736870</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-20-04075">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Van Esch</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hagedorn-Greiwe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Raynaud</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sperner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>J.-P.</given-names>
</name>
<name>
<surname>Schwinger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gécz</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation</article-title>
<source/>Am. J. Hum. Genet.
          <year>2004</year>
<volume>75</volume>
<fpage>1149</fpage>
<lpage>1154</lpage>
<pub-id pub-id-type="doi">10.1086/426460</pub-id>
<pub-id pub-id-type="pmid">15499549</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-20-04075">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weaving</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Friend</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>McKenzie</surname>
<given-names>O.L.D.</given-names>
</name>
<name>
<surname>Archer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pelka</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>P.P.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation</article-title>
<source/>Am. J. Hum. Genet.
          <year>2004</year>
<volume>75</volume>
<fpage>1079</fpage>
<lpage>1093</lpage>
<pub-id pub-id-type="doi">10.1086/426462</pub-id>
<pub-id pub-id-type="pmid">15492925</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-20-04075">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scala</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ariani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Caselli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pescucci</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Longo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Giachino</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bruttini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms</article-title>
<source/>J. Med. Genet.
          <year>2005</year>
<volume>42</volume>
<fpage>103</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.026237</pub-id>
<pub-id pub-id-type="pmid">15689447</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-20-04075">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fehr</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Murgia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sartori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vecchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Polli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Psoni</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2013</year>
<volume>21</volume>
<fpage>266</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2012.156</pub-id>
<pub-id pub-id-type="pmid">22872100</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-20-04075">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olson</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Demarest</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Pestana-Knight</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Devinsky</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Benke</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review</article-title>
<source/>Pediatr. Neurol.
          <year>2019</year>
<volume>97</volume>
<fpage>18</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2019.02.015</pub-id>
<pub-id pub-id-type="pmid">30928302</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-20-04075">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neul</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>M.E.S.</given-names>
</name>
<name>
<surname>Schanen</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Zappella</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rett syndrome: Revised diagnostic criteria and nomenclature</article-title>
<source/>Ann. Neurol.
          <year>2010</year>
<volume>68</volume>
<fpage>944</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22124</pub-id>
<pub-id pub-id-type="pmid">21154482</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-20-04075">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbiero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Peroni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tramarin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chandola</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The neurosteroid pregnenolone reverts microtubule derangement induced by the loss of a functional CDKL5-IQGAP1 complex</article-title>
<source/>Hum. Mol. Genet.
          <year>2017</year>
<volume>26</volume>
<fpage>3520</fpage>
<lpage>3530</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddx237</pub-id>
<pub-id pub-id-type="pmid">28641386</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-20-04075">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbiero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Valente</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chandola</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Magi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bergo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Monteonofrio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tramarin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fazzari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Soddu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CDKL5 localizes at the centrosome and midbody and is required for faithful cell division</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>6228</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-05875-z</pub-id>
<pub-id pub-id-type="pmid">28740074</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-20-04075">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baltussen</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Negraes</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Silvestre</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Claxton</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moeskops</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Snijders</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Muotri</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Ultanir</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Chemical genetic identification of CDKL5 substrates reveals its role in neuronal microtubule dynamics</article-title>
<source/>EMBO J.
          <year>2018</year>
<volume>37</volume>
<fpage>e99763</fpage>
<pub-id pub-id-type="doi">10.15252/embj.201899763</pub-id>
<pub-id pub-id-type="pmid">30266824</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-20-04075">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muñoz</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Peltier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weiland</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gregorczyk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Macartney</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Trost</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rouse</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase</article-title>
<source/>EMBO J.
          <year>2018</year>
<volume>37</volume>
<fpage>e99559</fpage>
<pub-id pub-id-type="doi">10.15252/embj.201899559</pub-id>
<pub-id pub-id-type="pmid">30266825</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-20-04075">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapitein</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Hoogenraad</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Building the Neuronal Microtubule Cytoskeleton</article-title>
<source/>Neuron
          <year>2015</year>
<volume>87</volume>
<fpage>492</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="pmid">26247859</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-20-04075">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varidaki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>E.T.</given-names>
</name>
</person-group>
<article-title>Repositioning Microtubule Stabilizing Drugs for Brain Disorders</article-title>
<source/>Front. Cell. Neurosci.
          <year>2018</year>
<volume>12</volume>
<fpage>226</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2018.00226</pub-id>
<pub-id pub-id-type="pmid">30135644</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-20-04075">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonini</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Mastinu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferrari-Toninelli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Memo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders</article-title>
<source/>Int. J. Mol. Sci.
          <year>2017</year>
<volume>18</volume>
<fpage>1627</fpage>
</element-citation>
</ref>
<ref id="B16-ijms-20-04075">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stiess</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Maghelli</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kapitein</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Gomis-Rüth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wilsch-Bräuninger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoogenraad</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Tolić-Nørrelykke</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Bradke</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Axon extension occurs independently of centrosomal microtubule nucleation</article-title>
<source/>Science
          <year>2010</year>
<volume>327</volume>
<fpage>704</fpage>
<lpage>707</lpage>
<pub-id pub-id-type="doi">10.1126/science.1182179</pub-id>
<pub-id pub-id-type="pmid">20056854</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-20-04075">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Willige</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hoogenraad</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Akhmanova</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Microtubule plus-end tracking proteins in neuronal development</article-title>
<source/>Cell. Mol. Life Sci.
          <year>2016</year>
<volume>73</volume>
<fpage>2053</fpage>
<lpage>2077</lpage>
<pub-id pub-id-type="pmid">26969328</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-20-04075">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Garnham</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Roll-Mecak</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Writing and Reading the Tubulin Code</article-title>
<source/>J. Biol. Chem.
          <year>2015</year>
<volume>290</volume>
<fpage>17163</fpage>
<lpage>17172</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.R115.637447</pub-id>
<pub-id pub-id-type="pmid">25957412</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-20-04075">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erck</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Peris</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Andrieux</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meissirel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Vernet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schweitzer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Saoudi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pointu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bosc</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A vital role of tubulin-tyrosine-ligase for neuronal organization</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2005</year>
<volume>102</volume>
<fpage>7853</fpage>
<lpage>7858</lpage>
<pub-id pub-id-type="pmid">15899979</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-20-04075">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halpain</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dehmelt</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The MAP1 family of microtubule-associated proteins</article-title>
<source/>Genome Biol.
          <year>2006</year>
<volume>7</volume>
<fpage>224</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2006-7-6-224</pub-id>
<pub-id pub-id-type="pmid">16938900</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-20-04075">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dehmelt</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Halpain</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Actin and microtubules in neurite initiation: Are MAPs the missing link?</article-title>
<source/>J. Neurobiol.
          <year>2004</year>
<volume>58</volume>
<fpage>18</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1002/neu.10284</pub-id>
<pub-id pub-id-type="pmid">14598367</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-20-04075">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akhmanova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Steinmetz</surname>
<given-names>M.O.</given-names>
</name>
</person-group>
<article-title>Tracking the ends: A dynamic protein network controls the fate of microtubule tips</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <year>2008</year>
<volume>9</volume>
<fpage>309</fpage>
<lpage>322</lpage>
<pub-id pub-id-type="doi">10.1038/nrm2369</pub-id>
<pub-id pub-id-type="pmid">18322465</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-20-04075">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Diamantopoulos</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Stalder</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kreis</surname>
<given-names>T.E.</given-names>
</name>
</person-group>
<article-title>CLIP-170 highlights growing microtubule ends in vivo</article-title>
<source/>Cell
          <year>1999</year>
<volume>96</volume>
<fpage>517</fpage>
<lpage>527</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80656-X</pub-id>
<pub-id pub-id-type="pmid">10052454</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-20-04075">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mustyatsa</surname>
<given-names>V.V.</given-names>
</name>
<name>
<surname>Boyakhchyan</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Ataullakhanov</surname>
<given-names>F.I.</given-names>
</name>
<name>
<surname>Gudimchuk</surname>
<given-names>N.B.</given-names>
</name>
</person-group>
<article-title>EB-Family Proteins: Functions and Microtubule Interaction Mechanisms</article-title>
<source/>Biochem. Mosc.
          <year>2017</year>
<volume>82</volume>
<fpage>791</fpage>
<lpage>802</lpage>
<pub-id pub-id-type="doi">10.1134/S0006297917070045</pub-id>
<pub-id pub-id-type="pmid">28918743</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-20-04075">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peris</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Thery</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fauré</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saoudi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lafanechère</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chilton</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Gordon-Weeks</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Galjart</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bornens</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wordeman</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends</article-title>
<source/>J. Cell Biol.
          <year>2006</year>
<volume>174</volume>
<fpage>839</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200512058</pub-id>
<pub-id pub-id-type="pmid">16954346</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-20-04075">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bieling</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kandels-Lewis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Telley</surname>
<given-names>I.A.</given-names>
</name>
<name>
<surname>van Dijk</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Janke</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Surrey</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>CLIP-170 tracks growing microtubule ends by dynamically recognizing composite EB1/tubulin-binding sites</article-title>
<source/>J. Cell Biol.
          <year>2008</year>
<volume>183</volume>
<fpage>1223</fpage>
<lpage>1233</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200809190</pub-id>
<pub-id pub-id-type="pmid">19103809</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-20-04075">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamura</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Draviam</surname>
<given-names>V.M.</given-names>
</name>
</person-group>
<article-title>Microtubule plus-ends within a mitotic cell are “moving platforms” with anchoring, signalling and force-coupling roles</article-title>
<source/>Open Biol.
          <year>2012</year>
<volume>2</volume>
<fpage>120132</fpage>
<pub-id pub-id-type="doi">10.1098/rsob.120132</pub-id>
<pub-id pub-id-type="pmid">23226599</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-20-04075">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witte</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Neukirchen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bradke</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Microtubule stabilization specifies initial neuronal polarization</article-title>
<source/>J. Cell Biol.
          <year>2008</year>
<volume>180</volume>
<fpage>619</fpage>
<lpage>632</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200707042</pub-id>
<pub-id pub-id-type="pmid">18268107</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-20-04075">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharp</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Baas</surname>
<given-names>P.W.</given-names>
</name>
</person-group>
<article-title>Transport of dendritic microtubules establishes their nonuniform polarity orientation</article-title>
<source/>J. Cell Biol.
          <year>1995</year>
<volume>130</volume>
<fpage>93</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.130.1.93</pub-id>
<pub-id pub-id-type="pmid">7790380</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-20-04075">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaworski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kapitein</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Gouveia</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Dortland</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Wulf</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Grigoriev</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Camera</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Spangler</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Di Stefano</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Demmers</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity</article-title>
<source/>Neuron
          <year>2009</year>
<volume>61</volume>
<fpage>85</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2008.11.013</pub-id>
<pub-id pub-id-type="pmid">19146815</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-20-04075">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lasser</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tiber</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lowery</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>The Role of the Microtubule Cytoskeleton in Neurodevelopmental Disorders</article-title>
<source/>Front. Cell. Neurosci.
          <year>2018</year>
<volume>12</volume>
<fpage>165</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2018.00165</pub-id>
<pub-id pub-id-type="pmid">29962938</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-20-04075">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Noritake</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matsuura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Iwamatsu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kaibuchi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170</article-title>
<source/>Cell
          <year>2002</year>
<volume>109</volume>
<fpage>873</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)00800-0</pub-id>
<pub-id pub-id-type="pmid">12110184</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-20-04075">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Reza Barzegar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rosén</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wågberg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Andreas Larsson</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>On the Stability and Abundance of Single Walled Carbon Nanotubes</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>16850</fpage>
<pub-id pub-id-type="doi">10.1038/srep16850</pub-id>
<pub-id pub-id-type="pmid">26581125</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-20-04075">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Z.-Q.</given-names>
</name>
</person-group>
<article-title>Molecular and Synaptic Bases of CDKL5 Disorder</article-title>
<source/>Dev Neurobiol
          <year>2019</year>
<volume>79</volume>
<fpage>8</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22639</pub-id>
<pub-id pub-id-type="pmid">30246934</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-20-04075">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nawaz</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Giarda</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bedogni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>La Montanara</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ricciardi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ciceri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Alberio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0148634</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0148634</pub-id>
<pub-id pub-id-type="pmid">26849555</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-20-04075">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchs</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Medici</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Trazzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gennaccaro</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Galvani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Berteotti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Loi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ciani</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling</article-title>
<source/>Brain Pathol.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1111/bpa.12716</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-20-04075">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conde</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cáceres</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Microtubule assembly, organization and dynamics in axons and dendrites</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2009</year>
<volume>10</volume>
<fpage>319</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2631</pub-id>
<pub-id pub-id-type="pmid">19377501</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-20-04075">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nirschl</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Magiera</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Lazarus</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Janke</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Holzbaur</surname>
<given-names>E.L.F.</given-names>
</name>
</person-group>
<article-title>α-Tubulin Tyrosination and CLIP-170 Phosphorylation Regulate the Initiation of Dynein-Driven Transport in Neurons</article-title>
<source/>Cell Rep.
          <year>2016</year>
<volume>14</volume>
<fpage>2637</fpage>
<lpage>2652</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.046</pub-id>
<pub-id pub-id-type="pmid">26972003</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-20-04075">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neukirchen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bradke</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Cytoplasmic linker proteins regulate neuronal polarization through microtubule and growth cone dynamics</article-title>
<source/>J. Neurosci.
          <year>2011</year>
<volume>31</volume>
<fpage>1528</fpage>
<lpage>1538</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3983-10.2011</pub-id>
<pub-id pub-id-type="pmid">21273437</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-20-04075">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbiero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Peroni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Siniscalchi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tramarin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>De Rosa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Motta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder</article-title>
<source/>Neuropharmacology
          <comment>under review</comment>
</element-citation>
</ref>
<ref id="B41-ijms-20-04075">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lansbergen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Komarova</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Modesti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wyman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hoogenraad</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Goodson</surname>
<given-names>H.V.</given-names>
</name>
<name>
<surname>Lemaitre</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Drechsel</surname>
<given-names>D.N.</given-names>
</name>
<name>
<surname>van Munster</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gadella</surname>
<given-names>T.W.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Conformational changes in CLIP-170 regulate its binding to microtubules and dynactin localization</article-title>
<source/>J. Cell Biol.
          <year>2004</year>
<volume>166</volume>
<fpage>1003</fpage>
<lpage>1014</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200402082</pub-id>
<pub-id pub-id-type="pmid">15381688</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-20-04075">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weng</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M.-R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>S.-K.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.-C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.-P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.-R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.-T.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>B.-C.</given-names>
</name>
</person-group>
<article-title>Pregnenolone activates CLIP-170 to promote microtubule growth and cell migration</article-title>
<source/>Nat. Chem. Biol.
          <year>2013</year>
<volume>9</volume>
<fpage>636</fpage>
<lpage>642</lpage>
<pub-id pub-id-type="doi">10.1038/nchembio.1321</pub-id>
<pub-id pub-id-type="pmid">23955365</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-20-04075">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toriyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shimada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Mitsuba</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Katsuta</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sakumura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Roepstorff</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Shootin1: A protein involved in the organization of an asymmetric signal for neuronal polarization</article-title>
<source/>J. Cell Biol.
          <year>2006</year>
<volume>175</volume>
<fpage>147</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200604160</pub-id>
<pub-id pub-id-type="pmid">17030985</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-20-04075">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kubo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Baba</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Toriyama</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Minegishi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sugiura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kozawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Shootin1-cortactin interaction mediates signal-force transduction for axon outgrowth</article-title>
<source/>J. Cell Biol.
          <year>2015</year>
<volume>210</volume>
<fpage>663</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201505011</pub-id>
<pub-id pub-id-type="pmid">26261183</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-20-04075">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CDKL5, a protein associated with rett syndrome, regulates neuronal morphogenesis via Rac1 signaling</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<fpage>12777</fpage>
<lpage>12786</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1102-10.2010</pub-id>
<pub-id pub-id-type="pmid">20861382</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-20-04075">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amendola</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mattucci</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Castroflorio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Calcagno</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lonetti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Silingardi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vyssotski</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mapping pathological phenotypes in a mouse model of CDKL5 disorder</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e91613</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0091613</pub-id>
<pub-id pub-id-type="pmid">24838000</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-20-04075">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>I.-T.J.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Terzic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pance</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Coulter</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice</article-title>
<source/>J. Neurosci.
          <year>2017</year>
<volume>37</volume>
<fpage>7420</fpage>
<lpage>7437</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0539-17.2017</pub-id>
<pub-id pub-id-type="pmid">28674172</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-20-04075">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okuda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Miyakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mizuguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<elocation-id>e0196587</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0196587</pub-id>
<pub-id pub-id-type="pmid">29702698</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-20-04075">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacquemet</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>IQGAP1 is a key node within the small GTPase network</article-title>
<source/>Small GTPases
          <year>2013</year>
<volume>4</volume>
<fpage>199</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.4161/sgtp.27451</pub-id>
<pub-id pub-id-type="pmid">24355937</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-20-04075">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swiech</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Blazejczyk</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Urbanska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pietruszka</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dortland</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Wulf</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Hoogenraad</surname>
<given-names>C.C.</given-names>
</name>
<name>
<surname>Jaworski</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>CLIP-170 and IQGAP1 cooperatively regulate dendrite morphology</article-title>
<source/>J. Neurosci.
          <year>2011</year>
<volume>31</volume>
<fpage>4555</fpage>
<lpage>4568</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6582-10.2011</pub-id>
<pub-id pub-id-type="pmid">21430156</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-20-04075">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramkumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jong</surname>
<given-names>B.Y.</given-names>
</name>
<name>
<surname>Ori-McKenney</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins</article-title>
<source/>Dev. Dyn.
          <year>2018</year>
<volume>247</volume>
<fpage>138</fpage>
<lpage>155</lpage>
<pub-id pub-id-type="pmid">28980356</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-20-04075">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ricciardi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ungaro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hambrock</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rademacher</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stefanelli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Sessa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Magagnotti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bachi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giarda</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons</article-title>
<source/>Nat. Cell Biol.
          <year>2012</year>
<volume>14</volume>
<fpage>911</fpage>
<lpage>923</lpage>
<pub-id pub-id-type="doi">10.1038/ncb2566</pub-id>
<pub-id pub-id-type="pmid">22922712</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-20-04075">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Della Sala</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Putignano</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chelini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Melani</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Calcagno</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Michele Ratto</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Amendola</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Giustetto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pizzorusso</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Dendritic Spine Instability in a Mouse Model of CDKL5 Disorder Is Rescued by Insulin-like Growth Factor 1</article-title>
<source/>Biol. Psychiatry
          <year>2016</year>
<volume>80</volume>
<fpage>302</fpage>
<lpage>311</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.028</pub-id>
<pub-id pub-id-type="pmid">26452614</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-20-04075">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamprecht</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>LeDoux</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Structural plasticity and memory</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2004</year>
<volume>5</volume>
<fpage>45</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1038/nrn1301</pub-id>
<pub-id pub-id-type="pmid">14708003</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-20-04075">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>La Montanara</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Locarno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Forti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Barbiero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tramarin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chandola</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Synaptic synthesis, dephosphorylation, and degradation: A novel paradigm for an activity-dependent neuronal control of CDKL5</article-title>
<source/>J. Biol. Chem.
          <year>2015</year>
<volume>290</volume>
<fpage>4512</fpage>
<lpage>4527</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M114.589762</pub-id>
<pub-id pub-id-type="pmid">25555910</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-20-04075">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Y.-C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S.-L.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Z.-Q.</given-names>
</name>
</person-group>
<article-title>Palmitoylation-dependent CDKL5-PSD-95 interaction regulates synaptic targeting of CDKL5 and dendritic spine development</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>9118</fpage>
<lpage>9123</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1300003110</pub-id>
<pub-id pub-id-type="pmid">23671101</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-20-04075">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gurgone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Castroflorio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Amendola</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sassoè-Pognetto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giustetto</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Lack of Cdkl5 Disrupts the Organization of Excitatory and Inhibitory Synapses and Parvalbumin Interneurons in the Primary Visual Cortex</article-title>
<source/>Front. Cell. Neurosci.
          <year>2016</year>
<volume>10</volume>
<fpage>261</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00261</pub-id>
<pub-id pub-id-type="pmid">27965538</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-20-04075">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tramarin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pizzamiglio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Barbiero</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Peroni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Scaramuzza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guilliams</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cavalla</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Antonucci</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5</article-title>
<source/>Hum. Mol. Genet.
          <year>2018</year>
<volume>27</volume>
<fpage>2052</fpage>
<lpage>2063</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddy108</pub-id>
<pub-id pub-id-type="pmid">29618004</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-20-04075">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Roncacé</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Trazzi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Medici</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gennaccaro</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Loi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Galvani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rimondini</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist</article-title>
<source/>Front. Cell. Neurosci.
          <year>2019</year>
<volume>13</volume>
<fpage>169</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2019.00169</pub-id>
<pub-id pub-id-type="pmid">31114483</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-20-04075">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yennawar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>F.E.</given-names>
</name>
</person-group>
<article-title>AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder</article-title>
<source/>J. Neurosci.
          <year>2019</year>
<volume>39</volume>
<fpage>4814</fpage>
<lpage>4828</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2041-18.2019</pub-id>
<pub-id pub-id-type="pmid">30952813</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-20-04075">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ethell</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Pasquale</surname>
<given-names>E.B.</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of dendritic spine development and remodeling</article-title>
<source/>Prog. Neurobiol.
          <year>2005</year>
<volume>75</volume>
<fpage>161</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2005.02.003</pub-id>
<pub-id pub-id-type="pmid">15882774</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-20-04075">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Viesselmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Merriam</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dent</surname>
<given-names>E.W.</given-names>
</name>
</person-group>
<article-title>Activity-dependent dynamic microtubule invasion of dendritic spines</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>13094</fpage>
<lpage>13105</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3074-08.2008</pub-id>
<pub-id pub-id-type="pmid">19052200</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-20-04075">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Firestein</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.Q.</given-names>
</name>
</person-group>
<article-title>Microtubules in dendritic spine development</article-title>
<source/>J. Neurosci.
          <year>2008</year>
<volume>28</volume>
<fpage>12120</fpage>
<lpage>12124</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2509-08.2008</pub-id>
<pub-id pub-id-type="pmid">19005076</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-20-04075">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schätzle</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Esteves da Silva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tas</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Katrukha</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Wierenga</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Kapitein</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Hoogenraad</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Activity-Dependent Actin Remodeling at the Base of Dendritic Spines Promotes Microtubule Entry</article-title>
<source/>Curr. Biol.
          <year>2018</year>
<volume>28</volume>
<fpage>2081</fpage>
<lpage>2093</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2018.05.004</pub-id>
<pub-id pub-id-type="pmid">29910073</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-20-04075">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pchitskaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kraskovskaya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chernyuk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Popugaeva</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vlasova</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Bezprozvanny</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Stim2-Eb3 Association and Morphology of Dendritic Spines in Hippocampal Neurons</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>17625</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-17762-8</pub-id>
<pub-id pub-id-type="pmid">29247211</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-20-04075">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schrick</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Tronson</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Penzes</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Radulovic</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>N-cadherin regulates cytoskeletally associated IQGAP1/ERK signaling and memory formation</article-title>
<source/>Neuron
          <year>2007</year>
<volume>55</volume>
<fpage>786</fpage>
<lpage>798</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.034</pub-id>
<pub-id pub-id-type="pmid">17785185</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-20-04075">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jausoro</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mestres</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Quassollo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Masseroni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Heredia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Caceres</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Regulation of spine density and morphology by IQGAP1 protein domains</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e56574</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0056574</pub-id>
<pub-id pub-id-type="pmid">23441206</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-20-04075">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Frausto</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Guedea</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Tronson</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Jovasevic</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Leaderbrand</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Corcoran</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Guzmán</surname>
<given-names>Y.F.</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Radulovic</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>IQGAP1 regulates NR2A signaling, spine density, and cognitive processes</article-title>
<source/>J. Neurosci.
          <year>2011</year>
<volume>31</volume>
<fpage>8533</fpage>
<lpage>8542</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1300-11.2011</pub-id>
<pub-id pub-id-type="pmid">21653857</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-20-04075">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nuriya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Phosphorylation-dependent interactions of alpha-Actinin-1/IQGAP1 with the AMPA receptor subunit GluR4</article-title>
<source/>J. Neurochem.
          <year>2005</year>
<volume>95</volume>
<fpage>544</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03410.x</pub-id>
<pub-id pub-id-type="pmid">16190873</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-20-04075">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.-H.J.</given-names>
</name>
<name>
<surname>Celic</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S.-Y.</given-names>
</name>
<name>
<surname>Riccomagno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.O.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Vasioukhin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Huganir</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Kolodkin</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Dlg5 regulates dendritic spine formation and synaptogenesis by controlling subcellular N-cadherin localization</article-title>
<source/>J. Neurosci.
          <year>2014</year>
<volume>34</volume>
<fpage>12745</fpage>
<lpage>12761</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1280-14.2014</pub-id>
<pub-id pub-id-type="pmid">25232112</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-20-04075">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandí</surname>
<given-names>M.-J.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Balan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Coyaud</surname>
<given-names>É.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Monson</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Ishiyama</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Chandrakumar</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>La Rose</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Couzens</surname>
<given-names>A.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MARK3-mediated phosphorylation of ARHGEF2 couples microtubules to the actin cytoskeleton to establish cell polarity</article-title>
<source/>Sci. Signal.
          <year>2017</year>
<volume>10</volume>
<fpage>eaan3286</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.aan3286</pub-id>
<pub-id pub-id-type="pmid">29089450</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-20-04075">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McVicker</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Awe</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Richters</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Cowdrey</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Dent</surname>
<given-names>E.W.</given-names>
</name>
</person-group>
<article-title>Transport of a kinesin-cargo pair along microtubules into dendritic spines undergoing synaptic plasticity</article-title>
<source/>Nat. Commun.
          <year>2016</year>
<volume>7</volume>
<fpage>12741</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms12741</pub-id>
<pub-id pub-id-type="pmid">27658622</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-20-04075">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schatten</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The mammalian centrosome and its functional significance</article-title>
<source/>Histochem. Cell Biol.
          <year>2008</year>
<volume>129</volume>
<fpage>667</fpage>
<lpage>686</lpage>
<pub-id pub-id-type="pmid">18437411</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-20-04075">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bettencourt-Dias</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Glover</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>Centrosome biogenesis and function: Centrosomics brings new understanding</article-title>
<source/>Nat. Rev. Mol. Cell Biol.
          <year>2007</year>
<volume>8</volume>
<fpage>451</fpage>
<lpage>463</lpage>
<pub-id pub-id-type="doi">10.1038/nrm2180</pub-id>
<pub-id pub-id-type="pmid">17505520</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-20-04075">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nigg</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Raff</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Centrioles, centrosomes, and cilia in health and disease</article-title>
<source/>Cell
          <year>2009</year>
<volume>139</volume>
<fpage>663</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.10.036</pub-id>
<pub-id pub-id-type="pmid">19914163</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-20-04075">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glotzer</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cytokinesis: GAP gap</article-title>
<source/>Curr. Biol.
          <year>2009</year>
<volume>19</volume>
<fpage>R162</fpage>
<lpage>R165</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2008.12.028</pub-id>
<pub-id pub-id-type="pmid">19243691</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-20-04075">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Surana</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Regulation of centrosome separation in yeast and vertebrates: Common threads</article-title>
<source/>Trends Cell Biol.
          <year>2009</year>
<volume>19</volume>
<fpage>325</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2009.03.008</pub-id>
<pub-id pub-id-type="pmid">19576775</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-20-04075">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staples</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Beveridge</surname>
<given-names>R.D.D.</given-names>
</name>
<name>
<surname>Patil</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A.J.X.</given-names>
</name>
<name>
<surname>Swanton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boulton</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Collis</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>The centriolar satellite protein Cep131 is important for genome stability</article-title>
<source/>J. Cell. Sci.
          <year>2012</year>
<volume>125</volume>
<fpage>4770</fpage>
<lpage>4779</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.104059</pub-id>
<pub-id pub-id-type="pmid">22797915</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-20-04075">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canning</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gonçalves</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Howard</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Sharpe</surname>
<given-names>T.D.</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Pelletier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bullock</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Leroux</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary Function</article-title>
<source/>Cell Rep.
          <year>2018</year>
<volume>22</volume>
<fpage>885</fpage>
<lpage>894</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.083</pub-id>
<pub-id pub-id-type="pmid">29420175</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-20-04075">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graser</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stierhof</surname>
<given-names>Y.-D.</given-names>
</name>
<name>
<surname>Lavoie</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Gassner</surname>
<given-names>O.S.</given-names>
</name>
<name>
<surname>Lamla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Le Clech</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nigg</surname>
<given-names>E.A.</given-names>
</name>
</person-group>
<article-title>Cep164, a novel centriole appendage protein required for primary cilium formation</article-title>
<source/>J. Cell Biol.
          <year>2007</year>
<volume>179</volume>
<fpage>321</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200707181</pub-id>
<pub-id pub-id-type="pmid">17954613</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-20-04075">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malicki</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>The Cilium: Cellular Antenna and Central Processing Unit</article-title>
<source/>Trends Cell Biol.
          <year>2017</year>
<volume>27</volume>
<fpage>126</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcb.2016.08.002</pub-id>
<pub-id pub-id-type="pmid">27634431</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-20-04075">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valente</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Rosti</surname>
<given-names>R.O.</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gleeson</surname>
<given-names>J.G.</given-names>
</name>
</person-group>
<article-title>Primary cilia in neurodevelopmental disorders</article-title>
<source/>Nat. Rev. Neurol.
          <year>2014</year>
<volume>10</volume>
<fpage>27</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1038/nrneurol.2013.247</pub-id>
<pub-id pub-id-type="pmid">24296655</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-20-04075">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tam</surname>
<given-names>L.-W.</given-names>
</name>
<name>
<surname>Ranum</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>CDKL5 regulates flagellar length and localizes to the base of the flagella in Chlamydomonas</article-title>
<source/>Mol. Biol. Cell.
          <year>2013</year>
<volume>24</volume>
<fpage>588</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.e12-10-0718</pub-id>
<pub-id pub-id-type="pmid">23283985</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-20-04075">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hector</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Kalscheuer</surname>
<given-names>V.M.</given-names>
</name>
<name>
<surname>Hennig</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Benke</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pineda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>M.E.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CDKL5 variants: Improving our understanding of a rare neurologic disorder</article-title>
<source/>Neurol. Genet.
          <year>2017</year>
<volume>3</volume>
<fpage>e200</fpage>
<pub-id pub-id-type="doi">10.1212/NXG.0000000000000200</pub-id>
<pub-id pub-id-type="pmid">29264392</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-20-04075">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertani</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bolognese</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Forlani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Conca</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>De Monte</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Badaracco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation</article-title>
<source/>J. Biol. Chem.
          <year>2006</year>
<volume>281</volume>
<fpage>32048</fpage>
<lpage>32056</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M606325200</pub-id>
<pub-id pub-id-type="pmid">16935860</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-20-04075">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rusconi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Salvatoni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giudici</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bertani</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kilstrup-Nielsen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Broccoli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail</article-title>
<source/>J. Biol. Chem.
          <year>2008</year>
<volume>283</volume>
<fpage>30101</fpage>
<lpage>30111</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M804613200</pub-id>
<pub-id pub-id-type="pmid">18701457</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-20-04075">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosas-Vargas</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nectoux</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Girard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>N’Guyen Morel</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Gitiaux</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lazaro</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Odent</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jonveaux</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy</article-title>
<source/>J. Med. Genet.
          <year>2008</year>
<volume>45</volume>
<fpage>172</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2007.053504</pub-id>
<pub-id pub-id-type="pmid">17993579</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-20-04075">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nectoux</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tallot</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chelly</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bienvenu</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndrome</article-title>
<source/>Clin. Genet.
          <year>2006</year>
<volume>70</volume>
<fpage>29</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2006.00629.x</pub-id>
<pub-id pub-id-type="pmid">16813600</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-20-04075">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cogliati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bonati</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Pintaudi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Veneselli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Saletti</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Balestrini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ben-Zeev</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Larizza</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes</article-title>
<source/>Neurogenetics
          <year>2009</year>
<volume>10</volume>
<fpage>241</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-009-0177-1</pub-id>
<pub-id pub-id-type="pmid">19241098</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-20-04075">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>I.-T.J.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Goffin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Fairless</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Brodkin</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Siegel</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Blendy</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>21516</fpage>
<lpage>21521</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1216988110</pub-id>
<pub-id pub-id-type="pmid">23236174</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-20-04075">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Terzic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>I.-T.J.</given-names>
</name>
<name>
<surname>Sarmiento</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sizov</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takano</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Coulter</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Altered NMDAR signaling underlies autistic-like features in mouse models of CDKL5 deficiency disorder</article-title>
<source/>Nat. Commun.
          <year>2019</year>
<volume>10</volume>
<fpage>2655</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-10689-w</pub-id>
<pub-id pub-id-type="pmid">31201320</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-20-04075">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szafranski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Golla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hixson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Matalon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kinney</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bock</surname>
<given-names>H.-G.</given-names>
</name>
<name>
<surname>Craigen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2015</year>
<volume>23</volume>
<fpage>915</fpage>
<lpage>921</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2014.217</pub-id>
<pub-id pub-id-type="pmid">25315662</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-20-04075">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchisella</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>E.T.</given-names>
</name>
<name>
<surname>Hollos</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Microtubule and microtubule associated protein anomalies in psychiatric disease</article-title>
<source/>Cytoskeleton (Hoboken)
          <year>2016</year>
<volume>73</volume>
<fpage>596</fpage>
<lpage>611</lpage>
<pub-id pub-id-type="doi">10.1002/cm.21300</pub-id>
<pub-id pub-id-type="pmid">27112918</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-20-04075">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunden</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>V.M.-Y.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Ballatore</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs</article-title>
<source/>Neurobiol. Dis.
          <year>2017</year>
<volume>105</volume>
<fpage>328</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2016.12.021</pub-id>
<pub-id pub-id-type="pmid">28012891</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-20-04075">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amos</surname>
<given-names>L.A.</given-names>
</name>
</person-group>
<article-title>Microtubule structure and its stabilisation</article-title>
<source/>Org. Biomol. Chem.
          <year>2004</year>
<volume>2</volume>
<fpage>2153</fpage>
<lpage>2160</lpage>
<pub-id pub-id-type="doi">10.1039/b403634d</pub-id>
<pub-id pub-id-type="pmid">15280946</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-20-04075">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maiti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shively</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lakhani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>McDonald-Jones</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bruce</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S.X.</given-names>
</name>
<name>
<surname>Joyce</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2005</year>
<volume>102</volume>
<fpage>227</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0406361102</pub-id>
<pub-id pub-id-type="pmid">15615853</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-20-04075">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunden</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Ballatore</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>V.M.-Y.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
</person-group>
<article-title>Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies</article-title>
<source/>Biochem. Soc. Trans.
          <year>2012</year>
<volume>40</volume>
<fpage>661</fpage>
<lpage>666</lpage>
<pub-id pub-id-type="doi">10.1042/BST20120010</pub-id>
<pub-id pub-id-type="pmid">22817712</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-20-04075">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trojanowski</surname>
<given-names>J.Q.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Iba</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Potuzak</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>A.-M.L.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S.X.</given-names>
</name>
<name>
<surname>Ballatore</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>3601</fpage>
<lpage>3611</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4922-11.2012</pub-id>
<pub-id pub-id-type="pmid">22423084</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-20-04075">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunden</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Potuzak</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>A.-M.L.</given-names>
</name>
<name>
<surname>Iba</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S.X.</given-names>
</name>
<name>
<surname>Ballatore</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy</article-title>
<source/>J. Neurosci.
          <year>2010</year>
<volume>30</volume>
<fpage>13861</fpage>
<lpage>13866</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3059-10.2010</pub-id>
<pub-id pub-id-type="pmid">20943926</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-20-04075">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gozes</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>NAP (davunetide) provides functional and structural neuroprotection</article-title>
<source/>Curr. Pharm. Des.
          <year>2011</year>
<volume>17</volume>
<fpage>1040</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.2174/138161211795589373</pub-id>
<pub-id pub-id-type="pmid">21524250</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-20-04075">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Helsmoortel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vulto-van Silfhout</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Vandeweyer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Rooms</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>van den Ende</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schuurs-Hoeijmakers</surname>
<given-names>J.H.M.</given-names>
</name>
<name>
<surname>Marcelis</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>L.E.L.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP</article-title>
<source/>Nat. Genet.
          <year>2014</year>
<volume>46</volume>
<fpage>380</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2899</pub-id>
<pub-id pub-id-type="pmid">24531329</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-20-04075">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kapitansky</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ivashco-Pachima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Malishkevich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Giladi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Skalka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rosin-Arbesfeld</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mittelman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Segev</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>J.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins</article-title>
<source/>Mol. Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>1115</fpage>
<lpage>1124</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.97</pub-id>
<pub-id pub-id-type="pmid">25178163</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-20-04075">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gozes</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>ADNP Regulates Cognition: A Multitasking Protein</article-title>
<source/>Front. Neurosci.
          <year>2018</year>
<volume>12</volume>
<fpage>873</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2018.00873</pub-id>
<pub-id pub-id-type="pmid">30534048</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-20-04075">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ivashko-Pachima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gozes</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>The ADNP derived peptide, NAP modulates the tubulin pool: Implication for neurotrophic and neuroprotective activities</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e51458</elocation-id>
<pub-id pub-id-type="pmid">23272107</pub-id>
</element-citation>
</ref>
<ref id="B105-ijms-20-04075">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gozes</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>The cytoskeleton as a drug target for neuroprotection: The case of the autism- mutated ADNP</article-title>
<source/>Biol. Chem.
          <year>2016</year>
<volume>397</volume>
<fpage>177</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1515/hsz-2015-0152</pub-id>
<pub-id pub-id-type="pmid">25955282</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-20-04075">
<label>106.</label>
<element-citation publication-type="web">
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.alzforum.org/">https://www.alzforum.org/</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2019-07-21">(accessed on 21 July 2019)</date-in-citation>
</element-citation>
</ref>
<ref id="B107-ijms-20-04075">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javitt</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Keefe</surname>
<given-names>R.S.E.</given-names>
</name>
<name>
<surname>Kern</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Csernansky</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>McEvoy</surname>
<given-names>J.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia</article-title>
<source/>Schizophr. Res.
          <year>2012</year>
<volume>136</volume>
<fpage>25</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2011.11.001</pub-id>
<pub-id pub-id-type="pmid">22169248</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-20-04075">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weng</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>B.-C.</given-names>
</name>
</person-group>
<article-title>Nongenomic actions of neurosteroid pregnenolone and its metabolites</article-title>
<source/>Steroids
          <year>2016</year>
<volume>111</volume>
<fpage>54</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/j.steroids.2016.01.017</pub-id>
<pub-id pub-id-type="pmid">26844377</pub-id>
</element-citation>
</ref>
<ref id="B109-ijms-20-04075">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flood</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Morley</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1992</year>
<volume>89</volume>
<fpage>1567</fpage>
<lpage>1571</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.89.5.1567</pub-id>
<pub-id pub-id-type="pmid">1531874</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-20-04075">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marx</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Hynan</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Davila</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sunderajan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression</article-title>
<source/>Neuropsychopharmacology
          <year>2014</year>
<volume>39</volume>
<fpage>2867</fpage>
<lpage>2873</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2014.138</pub-id>
<pub-id pub-id-type="pmid">24917198</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-20-04075">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osuji</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Vera-Bolaños</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Carmody</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>Pregnenolone for cognition and mood in dual diagnosis patients</article-title>
<source/>Psychiatry Res.
          <year>2010</year>
<volume>178</volume>
<fpage>309</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2009.09.006</pub-id>
<pub-id pub-id-type="pmid">20493557</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-20-04075">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baulieu</surname>
<given-names>E.-E.</given-names>
</name>
</person-group>
<article-title>3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>1713</fpage>
<lpage>1718</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1121485109</pub-id>
<pub-id pub-id-type="pmid">22307636</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-20-04075">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parésys</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Froger</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Villey</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Baulieu</surname>
<given-names>E.-E.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Effects of the Synthetic Neurosteroid: 3β-Methoxypregnenolone (MAP4343) on Behavioral and Physiological Alterations Provoked by Chronic Psychosocial Stress in Tree Shrews</article-title>
<source/>Int. J. Neuropsychopharmacol.
          <year>2016</year>
<volume>19</volume>
<fpage>pyv119</fpage>
<pub-id pub-id-type="doi">10.1093/ijnp/pyv119</pub-id>
<pub-id pub-id-type="pmid">26476437</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-20-04075-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Microtubule dynamics and post-translational modifications. (<bold>A</bold>) Microtubules (MTs) are composed of α- and β-tubulin heterodimers that assemble to linear proto-filaments that associate laterally, forming the hollow MT cylinder. Assembly, which is nucleated from the γ-tubulin ring, occurs in a polarised fashion with the β-tubulin subunit oriented towards the growing plus-end. Newly-incorporated tubulin is bound to guanosine triphosphate (GTP) that gets rapidly hydrolysed upon polymerisation, generating guanosine diphosphate (GDP)-bound tubulin along the MT lattice. (<bold>B</bold>) MTs are dynamic structures undergoing cycles of growth (polymerisation) and shrinkage (depolymerisation). The switch from growth to shrinkage is termed catastrophe, whereas rescue indicates the switch from shrinkage to growth. (<bold>C</bold>) The α-tubulin subunit can be acetylated on lysine (K) 40, which is located on the inner side of the MT. The C-terminal tail of α-tubulin projects away from the MT lattice and undergoes various post-translational modifications. The extreme tyrosine residue (Y) can be enzymatically removed, generating detyrosinated α-tubulin, which normally correlates with long-lived MTs. Further removal of the penultimate glutamate (E) generates ∆2-tubulin.</p>
</caption>
<graphic xlink:href="ijms-20-04075-g001"></graphic>
</fig>
<fig id="ijms-20-04075-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>The effect of CDKL5 deficiency on microtubule dynamics in axonal growth cones. (<bold>A</bold>) In the axon, microtubules (MTs) are organised in a polar fashion with the plus-ends oriented distally. The central domain, which is contiguous with the axonal shaft, is rich in MTs that are bound by plus-end tracking proteins (+TIPS) including CLIP170. The peripheral domain is rich in actin that extends into the filopodia. The transition zone, lying in between these two domains, contains antiparallel actin arcs that form a barrier against the invasion of MTs into the peripheral domain. (<bold>B</bold>) In the absence of CDKL5, CLIP170 is in its closed conformation and is less associated with the MT plus-ends impacting their capacity to engorge into the actin rich area and leading to cessation of axonal outgrowth.</p>
</caption>
<graphic xlink:href="ijms-20-04075-g002"></graphic>
</fig>
<fig id="ijms-20-04075-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>The effect of CDKL5 deficiency on dendritic microtubule dynamics. In dendrites, microtubules (MTs) have mixed orientations with the plus-ends oriented both proximally and distally. CDKL5 phosphorylates MAP1S inhibiting its binding to MTs (lower left). In the absence of CDKL5 (lower right), the binding of MAP1S to MTs is accompanied by increased life-time of EB3 binding to the plus-ends.</p>
</caption>
<graphic xlink:href="ijms-20-04075-g003"></graphic>
</fig>
<fig id="ijms-20-04075-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>The effect of CDKL5 deficiency on dendritic spine morphology. (<bold>A</bold>) Dendritic spines, which are enriched in actin, are invaded by microtubules (MTs) upon neuronal activation. The plus-end tracking proteins (+TIP), bound to the MT plus-ends, interact with actin-binding proteins facilitating the invasion. (<bold>B</bold>) In the absence of CDKL5, MTs are less dynamic and fail to invade the spines, impacting the activity-dependent structural changes that lead to the formation of mushroom-shaped spines.</p>
</caption>
<graphic xlink:href="ijms-20-04075-g004"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>